Ian David Brown

Ian David Brown

Director/Board Member chez BIOLIDICS LIMITED

Health Technology
Commercial Services
Consumer Services

Profil

Mr. Ian D.
Brown is an Independent Non-Executive Director at Biolidics Ltd., a Chief Executive Officer & Managing Director at Yallingup Ventures Pty Ltd., an Independent Chairman at Omniblend Innovation Pty Ltd.
and an Independent Chairman at Rex Ortho Pty Ltd.
He is on the Board of Directors at Biolidics Ltd.
Mr. Brown was previously employed as an Independent Chairman by Intergrain Pty Ltd., a Chief Executive Officer by RepRegen Ltd., a Chief Executive Officer & Managing Director by Avanti Capital, a Chief Operating Officer & Executive Director by Life Corp.
Ltd.
(Australia), and a Non-Executive Director by Recce Ltd.
He received his MBA from The University of Queensland.

Postes actifs de Ian David Brown

SociétésPosteDébut
BIOLIDICS LIMITED Director/Board Member 14/06/2021
Chairman -
Yallingup Ventures Pty Ltd. Chief Executive Officer 01/01/2011
Chairman -
Tous les postes actifs de Ian David Brown

Anciens postes connus de Ian David Brown

SociétésPosteFin
Chairman 29/04/2023
RECCE PHARMACEUTICALS LTD Director/Board Member 23/06/2016
Chief Executive Officer 01/01/2011
Chief Executive Officer 01/01/2009
CyGenics Ltd. Chief Operating Officer 01/01/2007
Voir l'expérience en détail de Ian David Brown

Formation de Ian David Brown

The University of Queensland Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ian David Brown

Relations

72

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
RECCE PHARMACEUTICALS LTD

Health Technology

BIOLIDICS LIMITED

Health Technology

Entreprise privées7
CyGenics Ltd.

Commercial Services

Health Services

Finance

Process Industries

Health Technology

Health Technology

Yallingup Ventures Pty Ltd.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Ian David Brown